Karl Deisseroth
Fondateur chez ClearLight Biotechnologies LLC
Profil
Karl Deisseroth is the founder of ClearLight Biotechnologies LLC, founded in 2014, and Stellaromics, Inc., founded in 2022.
He is also currently an advisor at Nan Fung Life Sciences.
Dr. Deisseroth earned a doctorate degree from Stanford University.
Postes actifs de Karl Deisseroth
| Sociétés | Poste | Début |
|---|---|---|
ClearLight Biotechnologies LLC
 ClearLight Biotechnologies LLC BiotechnologyHealth Technology ClearLight Biotechnologies LLC develops and commercializes tissue clearing technology. It provides innovative technologies to improve the diagnosis and treatment of diseases with an initial focus in oncology. The firm's technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The company was founded by Karl Deisseroth in 2014 and is headquartered in Mountain View, CA. | Fondateur | 01/01/2014 |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Consultant / Advisor | - |
Anciens postes connus de Karl Deisseroth
| Sociétés | Poste | Fin |
|---|---|---|
MapLight Therapeutics, Inc.
 MapLight Therapeutics, Inc. BiotechnologyHealth Technology MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA. | Fondateur | - |
Formation de Karl Deisseroth
| Stanford University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ClearLight Biotechnologies LLC
ClearLight Biotechnologies LLC BiotechnologyHealth Technology ClearLight Biotechnologies LLC develops and commercializes tissue clearing technology. It provides innovative technologies to improve the diagnosis and treatment of diseases with an initial focus in oncology. The firm's technique enables the transformation of tissue into a nanoporous, hydrogel-hybridized form that is crosslinked to a three-dimensional network of hydrophilic polymers. The company was founded by Karl Deisseroth in 2014 and is headquartered in Mountain View, CA. | Health Technology |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. BiotechnologyHealth Technology MapLight Therapeutics, Inc. engages in the development of novel therapeutics for brain disorders. The company is headquartered in San Francisco, CA. | Health Technology |
